RAMP 301 Aims to Solidify Avutometinib Plus Defactinib in Recurrent LGSOC
OncLive,
Jubilee Brown, MD As investigators continue efforts to improve outcomes for patients with low-grade serous ovarian cancer (LGSOC…
Jubilee Brown, MD As investigators continue efforts to improve outcomes for patients with low-grade serous ovarian cancer (LGSOC…
Low-grade serous ovarian cancer (LGSOC) presents differently than the more common high-grade serous carcinoma.
Summary Verastem focuses on anticancer agents, with recent promising ovarian cancer therapy data.